BOS161721
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BOS161721, covering 2022-03-14 to 2022-03-14. Get the full timeline:
Most recent: Clinical Trial Update: Study of BOS161721 in Systemic Lupus Erythematosus (SLE) Patients on a Background of Limited Standard of Care [Phase 1, Phase 2]